Here, we show that mice with IR and IGF1R-specific dual inhibition induced by OSI-906 at 45 mg/kg daily for 7 days developed lipodystrophy, steatosis, and β cell proliferation accompanied by hyperglycemic-hyperinsulinemia and hyperlipidemia. The gene discussed is IGF1R; the disease is hyperlipidemia.